Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma

American Journal of Clinical Pathology

Volumn 122, Issue 4, 2004, Pages 532-539

  Scolyer, Richard A ^a   Li, Ling Xi L ^a   McCarthy, Stanley W ^a   Shaw, Helen M ^a,b   Stretch, Jonathan R ^a,b   Sharma, Raghwa ^a,c   Thompson, John F ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Lymph node dissection; Melanoma; Micromorphometry; Morphology; Nonsentinel node; Pathology; Sentinel node; Staging; Tumor penetrative depth

Indexed keywords

ARTICLE; CANCER STAGING; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; MORPHOMETRICS; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

EID: 4644260554     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/TDWJTR15TDM1TG7Q     Document Type: Article

References (23)

1. McCarthy WH, Shaw HM, Cascinelli N, et al. Elective lymph node dissection for melanoma: two perspectives. World J Surg. 1992;16:203-213.
2. Urist MM, Maddox WA, Kennedy JE, et al. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer. 1983;51:2152-2156.
3. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255-260.
4. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
5. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol. 2000;7:469-474.
6. Stadelmann WK, Rapaport DP, Soong S-J. Prognostic clinical and pathological features. In: Balch CM, Houghton AN, Sober AJ, et al, eds. Cutaneous Melanoma. St Louis, MO: Quality Medical Publishing; 1998:11-35.
7. Cochran AJ, Balda BR, Starz H, et al. The Augsburg Consensus: techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer. 2000;89:236-241.
8. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110-2121.
9. Joseph E, Brobeil A, Glass F, et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998;5:119-125.
10. Cochran AJ, Wen DR, Morton DL. Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg. 1992;16:214-221.
11. Sim FH, Taylor WF, Ivins JC, et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: preliminary results. Cancer. 1978;41:948-956.
12. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420-2430.
13. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255-266.
14. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759-767.
15. Morton DL, Thompson JF, Essner R, et al, for the Multicenter Selective Lymphadenectomy Trial Group. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg. 1999;230:453-463.
16. Cochran AJ. Surgical pathology remains pivotal in the evaluation of "sentinel" lymph nodes. Am J Surg Pathol. 1999;23:1169-1172.
17. Scolyer RA, Li L-XL, McCarthy SW, et al. Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens. Melanoma Res. In press.
18. Salti GI, Das Gupta TK. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am J Surg. 2003;186:98-101.
19. Reeves ME, Delgado R, Busam KJ, et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol. 2003;10:27-31.
20. Wagner JD, Davidson D, Coleman JJ III, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol. 1999;6:398-404.
21. Movassagh M, Spatz A, Davoust J, et al. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res. 2004;64:2192-2198.
22. Barbour AH, Coventry BJ. Dendritic cell density and activation status of tumour-infiltrating lymphocytes in metastatic human melanoma: possible implications for sentinel node metastases. Melanoma Res. 2003;13:263-269.
23. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238:538-550.